Radforsk to invest NOK 4.5 million in cancer research
Radforsk, a partner of Oslo Cancer Cluster, is awarding several million Norwegian kroner to new research that fights cancer with light.
Should Norway implement a clinical trial league table?
We asked four MBA students from Cambridge University to evaluate how patient recruitment practices in Norway can be improved.
Hvordan gjør vi våre mest intime data til gull?
Helsedata er en voksende gullåre, men vi kan ikke grave i den uten videre.
Supporting cancer research with IP rights
Why are legal services an important part of Oslo Cancer Cluster? We asked Andrew Wright from Potter Clarkson to explain why they became a member.
Ny rapport: Helsenæringens verdi 2019
Rapporten gir innsikt i en næring som i 2018 omsatte for 142 milliarder kroner.
Meet our new members
Oslo Cancer Cluster proudly presents the new members who have joined our organisation during the first quarter of 2019.
